eloralintide vs cagrilintide Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight Eloralintide vs #Cagrilintide

Significant fat loss and muscle gains are typically most prominent at the 3 to 6 month mark

Batch: GF-AHK100-B242 Key analytical results include: Assay Content: 124.6 mg Identification Retention Time: 0.991 Identification Spectrum: 1000 Purity: greater than 99.8 percent Molecular Ion Mass Identification (MS Deconvolution): confirmed Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Product Overview AHK-Cu is a copper-binding synthetic peptide complex studied in controlled laboratory environments focused on peptide-mediated signalling pathways and molecular regulatory systems

2018;13(4): e0195909

10.1111/j.1365-2958.2006.05577.x